Company profile for Corstasis Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Corstasis is a healthcare technology company focused on developing innovative solutions to improve patient outcomes and optimize clinical workflows. Specializing in advanced data analytics and precision medicine, Corstasis aims to empower healthcare providers with actionable insights for better decision-making. Their cutting-edge platforms integrate AI and machine learning to enhance diagnostics, treatment planning, and patien...
Corstasis is a healthcare technology company focused on developing innovative solutions to improve patient outcomes and optimize clinical workflows. Specializing in advanced data analytics and precision medicine, Corstasis aims to empower healthcare providers with actionable insights for better decision-making. Their cutting-edge platforms integrate AI and machine learning to enhance diagnostics, treatment planning, and patient care, driving efficiency and effectiveness in modern healthcare systems.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3535 Executive Terminal Dr. Suite 110 Henderson, NV 89052
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251126808476/en/Corstasis-Therapeutics-and-Cardiovascular-Logistics-Partner-to-Redefine-Outpatient-Heart-Failure-Care-with-ENBUMYST-Bumetanide-Nasal-Spray

BUSINESSWIRE
26 Nov 2025

https://www.businesswire.com/news/home/20250924250761/en/Corstasis-Therapeutics-and-U.S.-Heart-and-Vascular-Collaboration-Will-Seek-to-Improve-Heart-Failure-Care-with-ENBUMYST-Bumetanide-Nasal-Spray

BUSINESSWIRE
25 Sep 2025

https://www.pharmiweb.com/press-release/2025-09-18/aptar-pharma-s-unidose-system-delivers-enbumyst-first-us-fda-approved-intranasal-diuretic

PHARMAWEB
18 Sep 2025

https://www.fiercepharma.com/pharma/corstasis-scores-fda-nod-nasal-spray-treatment-which-it-says-carries-multi-billion-sales

FIERCE PHARMA
16 Sep 2025

https://www.pharmiweb.com/press-release/2025-09-11/corstasis-therapeutics-strenghtens-leadership-team-with-the-appointment-of-dr-amin-medjamia-as-vp-o

PHARMAWEB
11 Sep 2025

https://www.businesswire.com/news/home/20250902731398/en/Corstasis-Therapeutics-Announces-Allowance-of-a-New-Patent-and-Development-Updates-for-Subcutaneous-Programs-RSQ-786-and-RSQ-789

BUSINESSWIRE
03 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty